Matrix metalloproteinase activation has been described in large cell lung carcinoma, where elevated CAV1 expression correlates with advanced stages of lung cancer as well as increased MMP9/MMP2 expression and activity. This evidence concerns the gene MMP9 and lung large cell carcinoma.